Summary
Johnson & Johnson (JNJ) filed an 8-K report on April 17, 2007, to announce its financial results for the first quarter ended April 1, 2007. This filing primarily serves to officially disclose the company's sales and earnings performance for the period, which was detailed in an accompanying press release and supplementary financial data. Investors can use this report to review J&J's latest financial performance and assess its operational health and market position as of early 2007.
Key Highlights
- 1J&J announced its first quarter 2007 sales and earnings results on April 17, 2007.
- 2The report confirms the release of a press release detailing the quarterly financial performance.
- 3Supplementary unaudited comparative sales data and condensed consolidated statements of earnings for Q1 2007 are included as exhibits.
- 4The filing is made pursuant to Item 2.02 (Results of Operations and Financial Condition) of Form 8-K.
- 5Stephen J. Cosgrove, Controller and Principal Accounting Officer, signed the report on behalf of Johnson & Johnson.
Frequently Asked Questions
The primary purpose of this 8-K filing is to officially announce and disclose Johnson & Johnson's sales and earnings results for the first quarter of 2007, which concluded on April 1, 2007.
The detailed financial results are contained within the attached press release (Exhibit 99.15) and the unaudited comparative supplementary sales data and condensed consolidated statements of earnings (Exhibit 99.20) that are part of this 8-K filing.
The filing announces sales and earnings for the first quarter ended April 1, 2007. The accompanying exhibits provide further details on these results, including supplementary sales data and condensed consolidated statements of earnings.